Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2009-12-18
2011-10-11
Cook, Lisa V (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S002000, C435S007100, C436S086000, C436S501000, C436S518000, C514S023000, C514S080000, C514S454000, C514S532000
Reexamination Certificate
active
08034576
ABSTRACT:
The present invention relates to diuretic pharmaceutical compositions and methods and in particular to certain derivatives of the formula I:or a prodrug or pharmaceutically acceptable salt thereof; anda pharmaceutically acceptable carrier.
REFERENCES:
patent: 3817837 (1974-06-01), Rubenstein et al.
patent: 4366241 (1982-12-01), Tom et al.
patent: 4376110 (1983-03-01), David et al.
patent: 4552884 (1985-11-01), Sim et al.
patent: 4559157 (1985-12-01), Smith et al.
patent: 4608392 (1986-08-01), Jacquet et al.
patent: 4620850 (1986-11-01), Bachmann et al.
patent: 4656188 (1987-04-01), Veber et al.
patent: 4938949 (1990-07-01), Borch et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 4992478 (1991-02-01), Geria
patent: 2003/0152622 (2003-08-01), Louie-Helm et al.
patent: 2004/0157917 (2004-08-01), Gobaille
patent: 2006/0217322 (2006-09-01), Bricker et al.
patent: 2047691 (1980-12-01), None
patent: WO-02/15942 (2002-02-01), None
patent: WO-03/005038 (2003-01-01), None
Ferre et al. Xanthurenic acid 8-O-beta-D-glucoside, a novel tryptophan metabolite in eye-color mutants ofDrosophilamelanogaster. Journal of Biological Chemistry. 260(12): pp. 7509-7514, 1985.
Shirao et al. Identification of a novel fluorophore, xanthurenic acid 8-O-beta-D-glucoside in human brunescent cataract. Experimental Eye Research. 73: pp. 421-431, 2001.
Cain et al. Identification of xanthurenic acid 8-O-beta-D-glucoside and xanthurenic acid 8-O-sulfate in human natriuretic hormones. PNAS, 104(45): pp. 17873-17878, Nov. 6, 2007.
Bricker et al., “Biologic and physical characteristics of the non-peptidic, non-digitalis-like natriuretic hormone”, Kidney International, 44: 937-947 (1993).
Buchli et al., Cloning and functional expression of a soluble form of kynurenine/α-aminoadipate aminotransferase from rat kidney, J. Biol. Chem. 270(49): 29330-29335 (1995).
Real and Ferre, “Biosynthesis of xanthurenic acid 8-O-β-D-glucoside in Drosophila”, J. Biol. Chem. 265 (13): 7407-7412 (1990).
Cairns and Payne, “The synthesis of 1-alkyl-1,4-dihydro-4-quinoline-2-carboxylic acids”, J. Heterocyclic Chem. 15: 551-553 (1978).
Ferre et al., “Xanthurenic acid 8-O-β-D-glucoside, a novel tryptophan metabolite in eye-color mutants of Drosophila melanogaster”, J. Biol. Chem., 260(12): 7509-7514 (1985).
Rocchini et al., “Urinary determination of tryptophan and related metabolites through HPLC in reverse phase”, Rassegna Chimica 36(1): 15-18 (1984).
Ishiguru et al., “Fluorescent substance in the body of bees”, Yakugaku Zasshi 94 (1) 116-23 (1974).
Kotake and Murakami, “A possible diabetogenic role for tryptophan matabolites and effects of xanthurenic acid on insulin”, American J. Clinical Nutrition 24 (7): 826-829 (1971).
Byran et al., “Mouse bladder carcinogenicity of certain tryptophan metabolites and other aromatic nitrogen compounds suspended in cholesterol”, Cancer Research 24 (4): 596-602 (1964).
Misra and Saxena, “Search for potential amoebicides II. synthesis of substituted (sulphazino) quinolines”, J. Indian Chem., Soc., 51 (11):967-969 (1974).
Misra et al., “Search for potential amoebicides: II, synthesis of substituted (-sulphazino) quinolines”, Acta Ciencia Indica: Chemistry 6 (1) 42-45 (1980).
Real and Ferre, “Distribution of xanthurenic acid glucoside in species of the genusDrosophila”, Insect Biochemisry 19(2): 111-116 (1989).
Sato et al., “Studies on conjugation of S35-sulfate with phenolic compounds”, the Journal of Biochemistry (Japan) 49(2): 164-168 (1961).
Sharma et al., “Synthesis and amoebicidal activity of novel substituted quinolines”, Indian J. Med. Res. 67: 165-169 (1978).
Shibata et al., “Synthesis of Zeanoside B, a metabolite of IAA in Zea mays L.”, Agric. Biol. Chem. 53 (3): 849-850 (1989).
Shirao et al., “Identification of a novel fluorophore, xanthurenic acid 8-O-β-D-glucoside in human brunescent cataract”, Exp. Eye Res. 73: 421-431 (2001).
Thiagarajan et al., “Role of xanthurenic acid 8-O-β-D-glucoside, a novel fluorophore that accumulates in the brunescent human eye lens”, Photochemistry and Photobiology 76(3): 368- 372 (2002).
Goodman and Gilman's The Pharmacological Basis for Therapeutics, 10thEd.; Hardman, Limbird & Gilman, Eds. MacGraw-Hill, p. 772, 2001.
Basic and Clinical Immunology, 4thEd., Chapter 22, “Immunologic Laboratory Tests. Clinical Laboratory Methods for Detection of Antigens and Antibodies” by D. P. Sites et al., published by Lange Medical Publications of Los Altos, Calif., in 1982.
Enzyme Immunoassay, edited by E.T. Maggio, “The EMIT-thyroxine assay”; Enzyme-mulitplied technique (EMIT®) published in 1980 by CRC Press, Inc., Boca Raton, Fla., pp. 141-150, 234-5, and 242-3.
D.S. Smith et al., “A Review of Fluroimmunossay and Immunoflurometric Assay”, Ann. Clin. Biochem. (1981) 18:253-274.
Huston et al, “Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced inEscherichia coli” Proc. Natl. Acad. Sci. USA, 85: 5879-83 (1988).
Ward et al, “Binding activities of a repertoire of a single immunoglobulin variable domains secreted fromEscherichia coli” Nature, 334: 544-46 (1989).
Köhler and Milstein, “Continuous cultures of fused cells secreting antibody of predefined specificity”, Nature, 256: 495-7 (1975).
Kozbor et al., “The production of monoclonal antibodies from human lymphocytes”, Immunology Today, 4:72 (1983).
Cote et al., “Generation of human monoclonal antibodies reative with cellular antigens”, Proc. Natl. Acad. Sci USA, 80:2026-30 (1983).
Cole et al., “The EBV-hybridoma technique and its application to human lung cancer”, in Monoclonal Antibodies and Cancer Therapy, Alan R. Liss, Inc., New York, pp. 77-96 (1985).
Morrison et al, “Chimeric human antibody moleculde: mouse antigen-binding domains with human constant region domains”, Proc. Natl. Acad. Sci., 81:6851-6855 (1984).
Huse et al., “Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda” Science, 246:1275-81 (1989).
Takeda et al, “Construction of chimeric processed immunoglobulin genes containing mouse variable and human constant region sequences”, Nature, 314:452-54 (1985).
Voller, “The Enzyme Linked Immunosorbent Assay (ELISA)”, Ric Clin Lab, 8:289-98 (1978).
Voller et al., “Enzyme immunoassays with special reference to ELISA techniques”, J. Clin. Pathol, 31:507-20 (1978).
Butler, “The amplified ELISA: Principles and applications for the comparative quantitiation of class and subclass antibodies and the distribution of antibodies and antigens in biochemical separates”, Meth. Enzymol., 73:482-523 (1981).
Dias et al, “The EMIT Cyclosporine Assay: development of application protocols for the Boehringer Mannheim Hitachi 911 and 917 analyzers”, Clin. Biochem. 1997 Mar 30 (2): 15562.
Bird et al., “Single-chain antigen-binding proteins”, Science 242:423-26 (1988).
Rich, R.L., et al., “High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE” Analytical Biochemistry, 2001, 296(2): p.197-207.
Marsilio et al., “Simultaneous HPLC determination with light-scattering detection of lactulose and mannitol in studies of intestinal permeability in pediatrics”, Clinical Chemistry; 44:16851691 (1998).
He et al., “Analysis of diagnostic metabolites by capillary electrophoresis-mass spectrometry”, J Chromatogr B Biomed Sci. Appl. Apr. 30, 1999; 727 (1-2):43-52.
Cain et al., Identification of xanthurenic acid 8-O-beta-D-glucoside and xanthurenic acid 8-O-sulfate as human natriuretic hormones, PNAS 2007, 104(45):17873-17878.
Theodoridis et
Bricker Neal
Cain Christopher D.
Mitchnick Mark
Schmertzler Michael
Shankel Stewart
Cook Lisa V
Edwards Angell Palmer & & Dodge LLP
Naturon, Inc.
Russett Mark D.
Williams Kathleen
LandOfFree
Xanthurenic acid derivative pharmaceutical compositions and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Xanthurenic acid derivative pharmaceutical compositions and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Xanthurenic acid derivative pharmaceutical compositions and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4281179